Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2005
Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels
Kathryn E Reinicke, Erik A Bey, Melissa S Bentle, et al.
Journal of Cellular Physiology
|
September 27, 2006
Mornings with Art, lessons learned: feedback regulation, restriction threshold biology, and redundancy govern molecular stress responses
Erik A Bey, Shelly M Wuerzberger-Davis, John J Pink, et al.
Investigational New Drugs
|
June 20, 2020
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors
Jennifer R Eads, Smitha S Krishnamurthi, Joel Saltzman, et al.
Molecular Cancer Therapeutics
|
July 26, 2013
Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers
Erik A Bey, Kathryn E Reinicke, Melissa C Srougi, et al.
The Journal of Clinical Investigation
|
October 22, 2024
Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical models
Ting-Yu Chang, Yan Yan, Zih-Yao Yu, et al.
Current Oncology (Toronto, Ont.)
|
June 4, 2020
A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes
S Ahmed, L Barbera, S J Bartlett, et al.
Contemporary Clinical Trials
|
September 14, 2025
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder Breast Cancer Patients (THRIVE 65)
Kathryn H Schmitz, Nathan A Berger, Cynthia Owusu, et al.
Vox Sanguinis
|
December 17, 2013
Should DEHP be eliminated in blood bags?
P F van der Meer, H W Reesink, S Panzer, et al.
Vox Sanguinis
|
August 27, 2016
International Forum regarding practices related to donor haemoglobin and iron
M Goldman, K Magnussen, J Gorlin, et al.
Vox Sanguinis
|
May 8, 2014
Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care
L Lieberman, D V Devine, H W Reesink, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2005
Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels
Kathryn E Reinicke, Erik A Bey, Melissa S Bentle, et al.
Journal of Cellular Physiology
|
September 27, 2006
Mornings with Art, lessons learned: feedback regulation, restriction threshold biology, and redundancy govern molecular stress responses
Erik A Bey, Shelly M Wuerzberger-Davis, John J Pink, et al.
Investigational New Drugs
|
June 20, 2020
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors
Jennifer R Eads, Smitha S Krishnamurthi, Joel Saltzman, et al.
Molecular Cancer Therapeutics
|
July 26, 2013
Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers
Erik A Bey, Kathryn E Reinicke, Melissa C Srougi, et al.
The Journal of Clinical Investigation
|
October 22, 2024
Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical models
Ting-Yu Chang, Yan Yan, Zih-Yao Yu, et al.
Current Oncology (Toronto, Ont.)
|
June 4, 2020
A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes
S Ahmed, L Barbera, S J Bartlett, et al.
Contemporary Clinical Trials
|
September 14, 2025
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder Breast Cancer Patients (THRIVE 65)
Kathryn H Schmitz, Nathan A Berger, Cynthia Owusu, et al.
Vox Sanguinis
|
December 17, 2013
Should DEHP be eliminated in blood bags?
P F van der Meer, H W Reesink, S Panzer, et al.
Vox Sanguinis
|
August 27, 2016
International Forum regarding practices related to donor haemoglobin and iron
M Goldman, K Magnussen, J Gorlin, et al.
Vox Sanguinis
|
May 8, 2014
Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care
L Lieberman, D V Devine, H W Reesink, et al.
Page
of 10